1. Home
  2. ATKR vs ADPT Comparison

ATKR vs ADPT Comparison

Compare ATKR & ADPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Atkore Inc.

ATKR

Atkore Inc.

HOLD

Current Price

$68.46

Market Cap

2.7B

Sector

Miscellaneous

ML Signal

HOLD

Logo Adaptive Biotechnologies Corporation

ADPT

Adaptive Biotechnologies Corporation

HOLD

Current Price

$20.60

Market Cap

2.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ATKR
ADPT
Founded
1959
2009
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Miscellaneous
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.7B
2.7B
IPO Year
2016
2019

Fundamental Metrics

Financial Performance
Metric
ATKR
ADPT
Price
$68.46
$20.60
Analyst Decision
Buy
Strong Buy
Analyst Count
4
9
Target Price
$75.67
$17.78
AVG Volume (30 Days)
365.8K
4.0M
Earning Date
05-05-2026
05-05-2026
Dividend Yield
1.75%
N/A
EPS Growth
N/A
63.89
EPS
N/A
N/A
Revenue
$2,850,378,000.00
$276,976,000.00
Revenue This Year
$6.55
$3.98
Revenue Next Year
$3.89
$22.72
P/E Ratio
N/A
N/A
Revenue Growth
N/A
54.77
52 Week Low
$53.49
$9.96
52 Week High
$90.16
$22.80

Technical Indicators

Market Signals
Indicator
ATKR
ADPT
Relative Strength Index (RSI) 35.04 61.16
Support Level $62.96 $15.08
Resistance Level $72.89 N/A
Average True Range (ATR) 2.84 1.15
MACD -1.34 0.14
Stochastic Oscillator 7.00 67.25

Price Performance

Historical Comparison
ATKR
ADPT

About ATKR Atkore Inc.

Atkore Inc is a manufacturer of Electrical products for the non-residential construction and renovation markets, as well as residential markets, and Safety & Infrastructure products for the construction and industrial markets. The Electrical segment manufactures products used in the construction of electrical power systems including conduit, cable, and installation accessories. This segment serves contractors in partnership with the electrical wholesale channel. The Safety & Infrastructure segment designs and manufactures solutions including metal framing, mechanical pipe, perimeter security, and cable management. These solutions are marketed to contractors, original equipment manufacturers (OEMs), and end-users. The majority of revenue is generated from the Electrical segment.

About ADPT Adaptive Biotechnologies Corporation

Adaptive Biotechnologies Corp is a company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is a test authorized by the FDA for the detection and monitoring of minimal residual disease (MRD) in patients with multiple myeloma (MM), B cell acute lymphoblastic leukemia (ALL) and chronic lymphocytic leukemia (CLL) and is also available as a CLIA-validated laboratory developed test (LDT) for patients with other lymphoid cancers. The company has two operating segments: Minimal Residual Disease and Immune Medicine. The company generates the majority of its revenue from the Minimal Residual Disease segment.

Share on Social Networks: